 Todos Medical Ltd announced that its majority-owned subsidiary 3CL Pharma, Ltd is reporting a case study from a patient with long COVID who was recommended Tollovid by her US physician. According to an abstract, the company said its subsidiary achieved a breakthrough with Post-Acute Sequelae of SARS-CoV-2 PASC, also known as long COVID, and its resolution following a course of the 3CL protease inhibitor dietary supplement Tollovid. 